AB Ignitis grupe (IGN)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 21.80 |
|---|---|
| 52-week range | 18.73 – 24.20 |
| Return, 1 month / 3 months | +4.3% / +4.3% |
| Return, 1 year / 3 years | +16.7% / +53.4% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 31.3% |
| Worst drawdown (1 year) | -8.8% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 6.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AB Ignitis grupe is an energy company based in Lithuania. It supplies electricity and natural gas to household and business customers, mainly in the Baltic region, and runs the distribution networks that deliver power to homes and firms. The company also generates and trades energy, including renewable output from wind and solar sources, and manages other energy-related activities across its home market and nearby countries.
AB Ignitis grupe trades under the code IGN on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AB Ignitis grupe (IGN) trades on the London Exchange in UK. It last closed at EUR 21.80 on 20 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,095 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.7% and over the last three months it rose 4.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 5.4% | ||
| From 52-week high | -1.8% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.3% | ||
| 6-month return | 9.8% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -8.8% | ||
| Liquidity | 9 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 3.3% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.9% |
|---|---|
| 1 month | +4.3% |
| 3 months | +4.3% |
| 6 months | +9.8% |
| 1 year | +16.7% |
| 3 years | +53.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 21.62 / 20.68 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.47 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Sep 2026 | EUR 0.7040 |
| 8 Apr 2026 | EUR 0.6830 |
| 23 Sep 2025 | EUR 0.6830 |
| 8 Apr 2025 | EUR 0.6630 |
| 24 Sep 2024 | EUR 0.6630 |
| 10 Apr 2024 | EUR 0.6430 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.